These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. From toxic precursors to safe drugs. Mechanisms and relevance of idiosyncratic drug reactions. Petersen KU. Arzneimittelforschung; 2002; 52(6):423-9. PubMed ID: 12109041 [Abstract] [Full Text] [Related]
27. Toxicophores, reactive metabolites and drug safety: when is it a cause for concern? Kalgutkar AS, Fate G, Didiuk MT, Bauman J. Expert Rev Clin Pharmacol; 2008 Jul; 1(4):515-31. PubMed ID: 24410554 [Abstract] [Full Text] [Related]
32. Idiosyncratic toxicity: the role of toxicophores and bioactivation. Williams DP, Park BK. Drug Discov Today; 2003 Nov 15; 8(22):1044-50. PubMed ID: 14690635 [Abstract] [Full Text] [Related]
33. Changes in gene expression induced by carbamazepine and phenytoin: testing the danger hypothesis. Lu W, Li X, Uetrecht JP. J Immunotoxicol; 2008 Apr 15; 5(2):107-13. PubMed ID: 18569379 [Abstract] [Full Text] [Related]
39. Idiosyncratic drug hepatotoxicity: strategy for prevention and proposed mechanism. Ikeda T. Curr Med Chem; 2015 Jun 15; 22(4):528-37. PubMed ID: 25245507 [Abstract] [Full Text] [Related]